Medallion Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
1,141
-109
-9% -$37.3K 0.13% 147
2026
Q1
$440K Buy
1,250
+151
+14% +$53.8K 0.14% 143
2025
Q4
$360K Sell
1,099
-73
-6% -$23.2K 0.12% 162
2025
Q3
$331K Buy
1,172
+1
+0.1% +$290 0.12% 169
2025
Q2
$336K Buy
1,171
+56
+5% +$15.9K 0.13% 162
2025
Q1
$344K Buy
1,115
+35
+3% +$10.3K 0.16% 142
2024
Q4
$302K Buy
+1,080
New +$320K 0.15% 146

Other funds holding AMGN

Medallion Wealth Advisors's AMGN Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Amgen (AMGN) stake by 8.7% in Q2 2026, selling an estimated $37.3K and leaving 1,141 shares worth $413K. The position accounts for 0.13% of the portfolio, ranked #147.

Medallion Wealth Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $440K in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Medallion Wealth Advisors held 1,141 shares of Amgen worth $413K as of Q2 2026.
  • Medallion Wealth Advisors sold 109 Amgen shares in Q2 2026, an estimated $37.3K.
  • Amgen made up 0.13% of Medallion Wealth Advisors's portfolio in Q2 2026, its #147 holding.
  • Medallion Wealth Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Amgen position peaked at $440K in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.